NDT Pharmaceuticals Inc.
Other OTCTotal Valuation
NDT Pharmaceuticals Inc. carries a market capitalization of 98.71M, placing it among publicly traded companies globally.
| Market Cap | 98.71M |
| Enterprise Value | N/A |
Share Statistics
NDT Pharmaceuticals Inc. currently has 42,350.00 shares outstanding.
| Shares Outstanding | 42,350.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -55,756.14 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
NDT Pharmaceuticals Inc.'s stock has gained approximately 768.87324% over the past 52 weeks. The 50-day moving average sits at 0.64, while the 200-day moving average is 0.96.
| Beta (5Y) | N/A |
| 52-Week Price Change | 768.87324% |
| 50-Day Moving Average | 0.64 |
| 200-Day Moving Average | 0.96 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -93,469.00, while operating income came in at -93,469.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -93,469.00 |
| Pretax Income | -187,778.00 |
| Net Income | -1.23M |
| EBITDA | -93,469.00 |
| EBIT | -93,469.00 |
| Earnings Per Share (EPS) | -29.32 |
Balance Sheet
Total book value stands at -1.26M, with working capital of -176,005.00 providing operational flexibility.
| Cash & Cash Equivalents | N/A |
| Total Debt | N/A |
| Net Debt | 158,284.00 |
| Equity (Book Value) | -1.26M |
| Book Value Per Share | -30.24 |
| Working Capital | -176,005.00 |
Cash Flow
NDT Pharmaceuticals Inc. produced -83,796.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -83,796.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -83,796.00 |
| FCF Per Share | -2.00 |
Stock Splits
NDT Pharmaceuticals Inc.'s most recent stock split took place on May 15, 2020 with a 1000:1 split ratio.
| Last Split Date | 5/15/2020 |
| Split Ratio | 1000:1 |
Scores
NDT Pharmaceuticals Inc. posts an Altman Z-Score of 151.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 151.04 |